APA (7th ed.) Citation

F, D., MM, O., EC, K. H., PF, C., IF, H., E, S., . . . R, D. (2025). Treatment sequence with tebentafusp and immune checkpoint inhibitors in patients with metastatic uveal melanoma and metastatic GNA11/GNAQ mutant melanocytic tumors. European journal of cancer (Oxford, England : 1990), 214, 115161. https://doi.org/10.1016/j.ejca.2024.115161

Chicago Style (17th ed.) Citation

F, Dimitriou, et al. "Treatment Sequence with Tebentafusp and Immune Checkpoint Inhibitors in Patients with Metastatic Uveal Melanoma and Metastatic GNA11/GNAQ Mutant Melanocytic Tumors." European Journal of Cancer (Oxford, England : 1990) 214 (2025): 115161. https://doi.org/10.1016/j.ejca.2024.115161.

MLA (9th ed.) Citation

F, Dimitriou, et al. "Treatment Sequence with Tebentafusp and Immune Checkpoint Inhibitors in Patients with Metastatic Uveal Melanoma and Metastatic GNA11/GNAQ Mutant Melanocytic Tumors." European Journal of Cancer (Oxford, England : 1990), vol. 214, 2025, p. 115161, https://doi.org/10.1016/j.ejca.2024.115161.